In this sense, Gong et al. found that serum ZAG levels were negatively associated with body weight and body fat percentage [15], and Wang et al. showed that serum ZAG levels were decreased in patients with metabolic syndrome and central obesity [11]. This evidence concerns the gene AZGP1 and Abdominal obesity.